Skip to content

Barricade Coil System 900111Recalls & reported problems

Balt USA LLC · Barricade Coil System (BCS) is intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The BCS is also intended for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolizations in the peripheral vasculature. The BCS consists of an implantable coil attached to a delivery pusher. The delivery pusher is powered by the Blockade Detachment Controller (BDC) designed specifically for the BCS. The device comes pre-loaded with one 9-volt battery. A BlockWire Connecting Cable or Handheld Detachment Cable, comprised of a red and black cable leads are required to detach Barricade Detachable Coils and must be used in conjunction with a return electrode. · Class 2 · Implant

All models of Barricade Coil System (18)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818053021107), received between Feb 22, 2021 and Feb 22, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Detachment of Device or Device Component1
  • Migration1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 22, 2021Detachment of Device or Device Component; Migration; Detachment of Device or Device Component; Migration

    IT WAS REPORTED THAT: "PROCEDURE: COILING. PATHOLOGY: ANEURYSM. ASSOCIATED PRODUCTS: FARGO MINI, VASCO10, CATCH 4*20, VASCO21D, HYBRID, BARRICADE, AXS CATALYST. A BILOBED ACOM ANEURYSM WAS PLANNED FOR TREATMENT BY SIMPLE COILING. 7F/80CM ARROW LONG SHEATH WAS PARKED IN THE LEFT COMMON CAROTID ARTERY. FARGO MINI WAS PARKED INTO PETROUS SEGMENT OF LEFT ICA.VASCO10MP WAS NAVIGATED OVER HYBRID 12 WIRE TO THE ANEURYSM. BARRICADE 6/20 COMPLEX FRAME COIL WAS DEPLOYED FIRST AND DETACHED. BARRICADE 2.5/4 COMPLEX FINISH COIL WAS DEPLOYED IN THE ANEURYSM. MULTIPLE ATTEMPTS WERE MADE TO DETACH THIS COIL BUT COIL DIDN'T DETACH. SO THE OPERATOR DECIDED TO WITHDRAW THE COIL HOWEVER THE COIL DETACHED PREMATURELY AND MIGRATED IN DISTAL ACA. LATER THIS COIL WAS RETRIEVED BY USING CATCH 4/20. AFTER THIS COILING WAS COMPLETED AND CASE WAS UNEVENTFUL."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11362967 ↗

Other Device, Neurovascular Embolization devices

All Device, Neurovascular Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page